First Time Loading...

Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 410 JPY 2.5% Market Closed
Updated: Apr 30, 2024
Sumitomo Pharma Co Ltd
/
Income Statement
/
Net Income (Common)

Sumitomo Pharma Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sumitomo Pharma Co Ltd
Net Income (Common) Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Net Income (Common)
-¥173.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income (Common)
¥178.2B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
2%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income (Common)
¥186.1B
CAGR 3-Years
38%
CAGR 5-Years
23%
CAGR 10-Years
5%
Otsuka Holdings Co Ltd
TSE:4578
Net Income (Common)
¥121.6B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income (Common)
¥325.5B
CAGR 3-Years
15%
CAGR 5-Years
29%
CAGR 10-Years
20%
Astellas Pharma Inc
TSE:4503
Net Income (Common)
¥37.3B
CAGR 3-Years
-35%
CAGR 5-Years
-29%
CAGR 10-Years
-9%

See Also

What is Sumitomo Pharma Co Ltd's Net Income (Common)?
Net Income (Common)
-173.7B JPY

Based on the financial report for Dec 31, 2023, Sumitomo Pharma Co Ltd's Net Income (Common) amounts to -173.7B JPY.

What is Sumitomo Pharma Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-1 956%

Over the last year, the Net Income (Common) growth was -1 956%.

ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.